ow intensity psychological support for people with personality disorder: Randomised controlled trial
- Conditions
- Specialty: Mental Health, Primary sub-specialty: Personality DisordersUKCRC code/ Disease: Mental Health/ Disorders of adult personality and behaviourMental and Behavioural DisordersPersonality disorder
- Registration Number
- ISRCTN14994755
- Brief Summary
2018 protocol in https://www.ncbi.nlm.nih.gov/pubmed/30305148 2020 results in https://pubmed.ncbi.nlm.nih.gov/32115015/ (added 05/03/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 63
1. Aged 18 or over
2. Clinical diagnosis of personality disorder
3. Positive screening result using the International Personality Disorder Examination self-administered questionnaire
4. Competent and willing to provide written, informed consent
1. A current clinical diagnosis of a co-existing organic or psychotic mental disorder (dementia, bipolar affective disorder (type I and II), delusional disorder, schizophrenia, schizoaffective disorder or schizotypal disorder
2. Cognitive or language difficulties that would preclude subjects providing informed consent or compromise participation in study procedures
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> Feasibility of the study is measured using the following:<br> 1. Recruitment of at least 80% of the study sample i.e 48 participants from the total of 60 we are aiming to recruit.<br> 2. Uptake of the low intensity intervention by at least 60% of participants in the active arm of the trial i.e. 18 of the 30 who are randomised to the low intensity intervention will have received it according to feedback from the therapist assigned to the participant.<br> 3. Completion of follow-up interviews at six months by 75% of study participants. To determine the feasibility of calculating a cost analysis of health economics, we will record completion rates for the cost data, and analyse them to determine what the cost-drivers are likely to be if proceeding to a full clinical trial.<br>
- Secondary Outcome Measures
Name Time Method